Kanos Pharmaceuticals, Inc.
1Patents
1Active
1Granted
43Portfolio score
Filing activity: Sep 28, 2016 → Sep 28, 2016
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9750740B2 | Spirocyclic compounds as tryptophan hydroxylase inhibitors | Emerging Cross-Sectional Technologies | 10 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.